4//SEC Filing
REPLIGEN CORP 4
Accession 0001140361-17-021757
$RGENCIK 0000730272operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:00 PM ET
Size
7.2 KB
Accession
0001140361-17-021757
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
COOPER GLENN L MD
Director
Transactions
- Award
Common Stock
2017-05-18+1,206→ 38,300 total - Award
Stock Option (Right to Buy)
2017-05-18+2,434→ 2,434 totalExercise: $38.76From: 2018-05-18Exp: 2027-05-18→ Common Stock (2,434 underlying)
Footnotes (2)
- [F1]Dr. Cooper was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full one year from grant date on May 18, 2018.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:00 PM ET
- Size
- 7.2 KB